about
The Role of Mir-148a in CancerMolecular Mechanisms of Right Ventricular FailureThe repressive effect of miR-148a on Wnt/β-catenin signaling involved in Glabridin-induced anti-angiogenesis in human breast cancer cellsmiR-148a Suppresses estrogen-induced viability and migration of breast cancer cells via inhibition of estrogen receptor α expression.Alterations in circulating miRNA levels following early-stage estrogen receptor-positive breast cancer resection in post-menopausal women.MicroRNA and mRNA cargo of extracellular vesicles from porcine adipose tissue-derived mesenchymal stem cells.Genetic polymorphisms in miRNAs targeting the estrogen receptor and their effect on breast cancer risk.Blockage of TGFβ-SMAD2 by demethylation-activated miR-148a is involved in caffeic acid-induced inhibition of cancer stem cell-like properties in vitro and in vivo.MiR-148a functions to suppress metastasis and serves as a prognostic indicator in triple-negative breast cancer.Differential Expression of microRNAs in Urinary Extracellular Vesicles Obtained From Hypertensive Patients.Human epidermal growth factor receptor 3 (HER3) blockade with U3-1287/AMG888 enhances the efficacy of radiation therapy in lung and head and neck carcinoma.Lactogenic hormones alter cellular and extracellular microRNA expression in bovine mammary epithelial cell cultureEmerging anti-cancer antibodies and combination therapies targeting HER3/ERBB3.Characterization and biological function of milk-derived miRNAs.Glabridin inhibits cancer stem cell-like properties of human breast cancer cells: An epigenetic regulation of miR-148a/SMAd2 signaling.MicroRNA-148a represents an independent prognostic marker in bladder cancer.SNP rs3202538 in 3'UTR region of ErbB3 regulated by miR-204 and miR-211 promote gastric cancer development in Chinese population.Down-regulation of miRNA-148a and miRNA-625-3p in colorectal cancer is associated with tumor budding.Tumor suppressor control of the cancer stem cell niche.MicroRNA expression patterns in canine mammary cancer show significant differences between metastatic and non-metastatic tumours.The role of the miR-148/-152 family in physiology and disease.c-Met and miRs in Cancer.Inhibition of HER3 activation and tumor growth with a human antibody binding to a conserved epitope formed by domain III and IV.SPIN1, negatively regulated by miR-148/152, enhances Adriamycin resistance via upregulating drug metabolizing enzymes and transporter in breast cancer.Posttranscriptional upregulation of HER3 by HER2 mRNA induces trastuzumab resistance in breast cancer
P2860
Q26743549-1CC49A75-6F2B-4095-A354-C09667F89B9EQ28087397-4C5F8252-578D-40AB-AEF9-6EFAFDA3E1BEQ33630327-4B924752-8440-49A6-8481-42804C81186BQ33724284-DD462892-AD71-4B4B-B79F-A405EE45E8E1Q33864278-0B51452F-10C7-4C04-8FB6-26745D209F66Q34241814-8D302EEC-AE6B-41BC-855E-0FE0D0D549F5Q34879842-0FAD96DB-8BE3-4E7B-A10D-A4C4E71DFFA8Q35763804-60F623E2-66BD-46FC-B9DB-8F4671FB415DQ37190321-CD257FCE-A658-4036-8256-39D418B05352Q37443294-3A0B58C1-C1FC-48AF-8CB7-6D4EC464C864Q37515219-2973FB79-7E4C-44BD-B31D-E937E55D5CB1Q38526962-3AFCBEC2-A7F1-4F56-89CC-210BC5DC217AQ38623361-DB0C3F01-3E55-41D5-814D-0E880C82E80AQ38667643-356996F2-618F-4640-9215-B063AFDC1A6AQ38874118-9C2AB422-2685-4A47-8039-8E3C1C4D155BQ41024564-DA603B61-6201-4C94-8075-80B629CC30D5Q41036589-892D4ADE-4434-4B95-9381-B7F4D22FCF94Q41589141-30E4CA0B-CEC5-436C-8B04-7AD4E7C7EF0AQ42486439-226FB4F3-4DBF-4756-A6F3-CF87475B15B4Q47633999-E31A2B64-E304-498C-A645-79CC6FF28BABQ48111289-D50CB7AF-1C50-41BA-9C5D-95A062714805Q51158233-2A895B7A-BDF6-4DAD-9A82-F02D775760AFQ55000376-91A8CDC5-C861-486F-B105-831634E6A5E6Q55360446-1251E2F4-3290-4C82-8DCD-BB7C6369D293Q58803127-13947343-BD65-407F-BBCF-F20025BC2BC1
P2860
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
2011年论文
@zh
2011年论文
@zh-cn
name
MiR-148a inhibits angiogenesis by targeting ERBB3.
@ast
MiR-148a inhibits angiogenesis by targeting ERBB3.
@en
type
label
MiR-148a inhibits angiogenesis by targeting ERBB3.
@ast
MiR-148a inhibits angiogenesis by targeting ERBB3.
@en
prefLabel
MiR-148a inhibits angiogenesis by targeting ERBB3.
@ast
MiR-148a inhibits angiogenesis by targeting ERBB3.
@en
P2093
P2860
P1476
MiR-148a inhibits angiogenesis by targeting ERBB3.
@en
P2093
P2860
P304
P356
10.1016/S1674-8301(11)60022-5
P577
2011-05-01T00:00:00Z